TY  - GEN
AU  - Sahraoui,Y
AU  - Perraki,M
AU  - Theodoropoulou,M
AU  - Allouche,M
AU  - Tsapis,A
AU  - Ammar,A
AU  - Clemenceau,C
AU  - Bokogiorgou,S
AU  - Yacci,T
AU  - Katrinakis,G
AU  - Jasmin,C
AU  - Georgoulias,V
TI  - Autocrine IL-2-dependent growth of a newly established CD3+, CD16-, CD56+, CD57+, J(H)-, TCRbeta-, TCRgamma- leukemia cell line (NOI-90)
SN  - 0887-6924
PY  - 1997///0224
KW  - CD3 Complex
KW  - analysis
KW  - CD56 Antigen
KW  - CD57 Antigens
KW  - Culture Media, Conditioned
KW  - pharmacology
KW  - Embryonal Carcinoma Stem Cells
KW  - Fatal Outcome
KW  - Fluorescent Antibody Technique, Indirect
KW  - Gene Rearrangement
KW  - Humans
KW  - Immunoglobulin Heavy Chains
KW  - Immunophenotyping
KW  - Interleukin-2
KW  - Male
KW  - Middle Aged
KW  - Neoplastic Stem Cells
KW  - drug effects
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - pathology
KW  - Receptors, Antigen, T-Cell, alpha-beta
KW  - Receptors, Antigen, T-Cell, gamma-delta
KW  - Receptors, IgG
KW  - Tumor Cells, Cultured
N1  - Publication Type: Case Reports; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.leu.2400562
ER  -